search
Back to results

A Video Intervention to Decrease Patient Fear of Colonoscopy After a Positive Fecal Immunochemical Test

Primary Purpose

Colorectal Carcinoma

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Media Intervention
Best Practice
Questionnaire Administration
Sponsored by
Fred Hutchinson Cancer Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Colorectal Carcinoma

Eligibility Criteria

45 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 45-75
  • Have an assigned primary care provider in our partnering safety-net health system
  • Have a billable primary care encounter between 2019-2022
  • Have an abnormal FIT result for colorectal cancer (CRC) screening without a colonoscopy within 1 year
  • Ability to communicate in English due to initial videos being available in English

Exclusion Criteria:

  • Adults < age 45 or > age 75
  • Patients who receive care at other University of Washington (UW) medicine sites (non-safety-net patients)
  • Individuals without a primary care encounter between 2019-2022
  • Individuals whose primary language is not English

Sites / Locations

  • Fred Hutch/University of Washington Cancer ConsortiumRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Arm 1 (educational video)

Arm 2 (usual care)

Arm Description

Patients watch an educational video about the importance of abnormal FIT results, the implications if follow-up colonoscopy is not completed, and demonstrate the steps to complete a colonoscopy.

Patients receive usual care and do not watch the educational video.

Outcomes

Primary Outcome Measures

Feasibility as measured by study accrual
Feasibility will be measured by recruitment as the proportion of invited participants who consent and complete the pilot study.
Feasibility: number of contacts needed to reach target enrollment
Feasibility will be measured by recruitment as the number of contacts required to reach target enrollment.
Feasibility: time to reach recruitment
Feasibility will be measured by recruitment as the time required to reach target enrollment. Time to reach recruitment target will be measured in days and described using medians and interquartile range (IQR).
Acceptability of the video intervention assessed by a survey
Intervention arm patients will complete a post-intervention survey to assess acceptability of the intervention using the Acceptability of Intervention Measure (AIM), a 4-item measure. Items are rated on a 5-point Likert Scale (1, completely disagree; 5, completely agree). Mean scores will be calculated to generate an average AIM score, where higher scores will indicate higher levels of acceptability.
Incidence of fear related to colonoscopy
Intervention arm patients will complete a pre- and post-intervention survey that will include questions about fear of colonoscopy. Usual care patients will complete a baseline survey on the same measures. Fear will be assessed using Manne's 6-item fear of colonoscopy scale. Items are rated on a 5-point Likert scale (1, not at all fearful; 5, extremely fearful). Mean scores will be calculated to generate average fear per participant, with higher scores indicating higher levels of fear.
Knowledge about colonoscopy
Intervention arm patients will complete a pre- and post-intervention survey that will include questions about knowledge about colon cancer screening. Usual care patients will complete a baseline survey on the same measures. Knowledge will be measured using 8 validated questions. Incorrect answers will be scored as 0 and correct answers scored as 1. Higher scores will indicate higher levels of knowledge.
Self-efficacy related to colonoscopy
Intervention arm patients will complete a pre- and post-intervention survey that will include questions about self-efficacy related to a colonoscopy. Usual care patients will complete a baseline survey on the same measures. Self-efficacy will be assessed by adopting an 8-item self-efficacy scale for colonoscopy completion in patients with inflammatory bowel diseases and responses will be recorded on a 5-point scale. Higher scores will indicate higher levels of self-efficacy.
Intent to complete a colonoscopy
Intervention arm patients will complete a pre- and post-intervention survey that will include questions about intent to complete a colonoscopy. Usual care patients will complete a baseline survey on the same measures. Intent will be measured using a single validated question on a nominal scale with 5 options. Responses will be dichotomized to affirmative intent (definitely will do, will do) or uncertain intent (don't know, will not do, and definitely will not do).

Secondary Outcome Measures

Incidence of completed colonoscopies
Through review of the electronic health records (EHR), the investigators will determine rates of completed colonoscopy 6 months after randomization to assess preliminary efficacy.

Full Information

First Posted
July 1, 2022
Last Updated
May 23, 2023
Sponsor
Fred Hutchinson Cancer Center
Collaborators
American College of Gastroenterology
search

1. Study Identification

Unique Protocol Identification Number
NCT05458986
Brief Title
A Video Intervention to Decrease Patient Fear of Colonoscopy After a Positive Fecal Immunochemical Test
Official Title
A Pilot Video Intervention to Decrease Fear of Colonoscopy in a Safety-Net Healthcare System
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 15, 2023 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fred Hutchinson Cancer Center
Collaborators
American College of Gastroenterology

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This clinical trial compares an educational video intervention versus usual care of no video intervention in decreasing patient fear of a colonoscopy procedure after receiving a positive fecal immunochemical test (FIT). The lack of a follow-up colonoscopy after an abnormal FIT result is associated with an increased risk of colorectal cancer mortality, advanced-stage colorectal cancer, among other complications, compared to the completion of a follow-up colonoscopy. An educational video may reduce patient fear and increase knowledge, self-efficacy, and intent to complete a colonoscopy compared to the usual care of no video intervention.
Detailed Description
OUTLINE: Patients are randomized to 1 of 2 arms. ARM 1: Patients watch an educational video about the importance of abnormal FIT results, the implications if follow-up colonoscopy is not completed, and demonstrate the steps to complete a colonoscopy. ARM 2: Patients receive usual care and do not watch the educational video. After completion of study, patients are followed for 12 months after their abnormal FIT result.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Carcinoma

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Arm 1 (educational video)
Arm Type
Experimental
Arm Description
Patients watch an educational video about the importance of abnormal FIT results, the implications if follow-up colonoscopy is not completed, and demonstrate the steps to complete a colonoscopy.
Arm Title
Arm 2 (usual care)
Arm Type
Active Comparator
Arm Description
Patients receive usual care and do not watch the educational video.
Intervention Type
Other
Intervention Name(s)
Media Intervention
Intervention Description
Watch an educational video
Intervention Type
Other
Intervention Name(s)
Best Practice
Intervention Description
Receive usual care
Intervention Type
Other
Intervention Name(s)
Questionnaire Administration
Intervention Description
Ancillary studies
Primary Outcome Measure Information:
Title
Feasibility as measured by study accrual
Description
Feasibility will be measured by recruitment as the proportion of invited participants who consent and complete the pilot study.
Time Frame
Up to 12 months post-abnormal fecal immunochemical test (FIT) result
Title
Feasibility: number of contacts needed to reach target enrollment
Description
Feasibility will be measured by recruitment as the number of contacts required to reach target enrollment.
Time Frame
Up to 12 months post-abnormal FIT result
Title
Feasibility: time to reach recruitment
Description
Feasibility will be measured by recruitment as the time required to reach target enrollment. Time to reach recruitment target will be measured in days and described using medians and interquartile range (IQR).
Time Frame
Up to 12 months post-abnormal FIT result
Title
Acceptability of the video intervention assessed by a survey
Description
Intervention arm patients will complete a post-intervention survey to assess acceptability of the intervention using the Acceptability of Intervention Measure (AIM), a 4-item measure. Items are rated on a 5-point Likert Scale (1, completely disagree; 5, completely agree). Mean scores will be calculated to generate an average AIM score, where higher scores will indicate higher levels of acceptability.
Time Frame
Up to 12 months post-abnormal FIT result
Title
Incidence of fear related to colonoscopy
Description
Intervention arm patients will complete a pre- and post-intervention survey that will include questions about fear of colonoscopy. Usual care patients will complete a baseline survey on the same measures. Fear will be assessed using Manne's 6-item fear of colonoscopy scale. Items are rated on a 5-point Likert scale (1, not at all fearful; 5, extremely fearful). Mean scores will be calculated to generate average fear per participant, with higher scores indicating higher levels of fear.
Time Frame
Up to 12 months post-abnormal FIT result
Title
Knowledge about colonoscopy
Description
Intervention arm patients will complete a pre- and post-intervention survey that will include questions about knowledge about colon cancer screening. Usual care patients will complete a baseline survey on the same measures. Knowledge will be measured using 8 validated questions. Incorrect answers will be scored as 0 and correct answers scored as 1. Higher scores will indicate higher levels of knowledge.
Time Frame
Up to 12 months post-abnormal FIT result
Title
Self-efficacy related to colonoscopy
Description
Intervention arm patients will complete a pre- and post-intervention survey that will include questions about self-efficacy related to a colonoscopy. Usual care patients will complete a baseline survey on the same measures. Self-efficacy will be assessed by adopting an 8-item self-efficacy scale for colonoscopy completion in patients with inflammatory bowel diseases and responses will be recorded on a 5-point scale. Higher scores will indicate higher levels of self-efficacy.
Time Frame
Up to 12 months post-abnormal FIT result
Title
Intent to complete a colonoscopy
Description
Intervention arm patients will complete a pre- and post-intervention survey that will include questions about intent to complete a colonoscopy. Usual care patients will complete a baseline survey on the same measures. Intent will be measured using a single validated question on a nominal scale with 5 options. Responses will be dichotomized to affirmative intent (definitely will do, will do) or uncertain intent (don't know, will not do, and definitely will not do).
Time Frame
Up to 12 months post-abnormal FIT result
Secondary Outcome Measure Information:
Title
Incidence of completed colonoscopies
Description
Through review of the electronic health records (EHR), the investigators will determine rates of completed colonoscopy 6 months after randomization to assess preliminary efficacy.
Time Frame
At 6 months post randomization

10. Eligibility

Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 45-75 Have an assigned primary care provider in our partnering safety-net health system Have a billable primary care encounter between 2019-2022 Have an abnormal FIT result for colorectal cancer (CRC) screening without a colonoscopy within 1 year Ability to communicate in English due to initial videos being available in English Exclusion Criteria: Adults < age 45 or > age 75 Patients who receive care at other University of Washington (UW) medicine sites (non-safety-net patients) Individuals without a primary care encounter between 2019-2022 Individuals whose primary language is not English
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ari Bell-Brown, MPH
Phone
206.667.7624
Email
abellbro@fredhutch.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rachel Issaka, MD, MAS
Organizational Affiliation
Fred Hutch/University of Washington Cancer Consortium
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fred Hutch/University of Washington Cancer Consortium
City
Seattle
State/Province
Washington
ZIP/Postal Code
98109
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ari Bell-Brown, MPH
Phone
206-667-7624
Email
abellbro@fredhutch.org
First Name & Middle Initial & Last Name & Degree
Rachel Issaka, MD, MAS

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

A Video Intervention to Decrease Patient Fear of Colonoscopy After a Positive Fecal Immunochemical Test

We'll reach out to this number within 24 hrs